Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zist Takavari Taravat Zendegi (ZTTZ) is an Iranian knowledge-based biotechnology company focused on the development and production of advanced probiotic products and biological supplements. The company specializes in the formulation of synbiotics and specialized probiotic strains for human consumption, aiming to improve gastrointestinal health and immune function. ZTTZ operates modern manufacturing facilities that adhere to international quality standards to serve the domestic and regional healthcare markets. Their product portfolio includes various supplements designed for different age groups and specific health conditions, leveraging microbial biotechnology to enhance patient well-being.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zyest Technology Tarawat Zendig.